FOXD1 and familial pancreatic carcinoma: Previous studies showed that activation of FOXD1 may induce the ERK signaling pathway and chemotherapeutic drug resistance 12,13, and we also confirmed that ERK signaling pathway was inhibited after FOXD1 knockdown in pancreatic cancer (Figure 5E).